Oisín Biotechnologies

Developer of genetically targeted intervention therapy for age-related diseases

placeSeattle, Washington, United States calendar_todayFounded 2014 groups18 employees language oisinbio.com

Registered entities

Social engagement

Social engagement: 2.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Althea Group, AbbVie.

Investor typeCountShare
Venture capital333%
Private equity111%
Bank & private debt111%
Other / undisclosed444%
Coming soon